Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.35 |
| ▸ | THRA | P10827 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | PDIA6 | Q15084 | 1/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.34 |
| ▸ | ESR1 | P03372 | 3/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.34 |
| ▸ | WDR5 | P61964 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5844944 | 0.99 | S1PR3 (0.39) | LMNAHTTS1PR3TSHRSMN1; SMN2 | |
| SCHEMBL5843958 | 0.99 | S1PR3 (0.39) | LMNAHTTS1PR3TSHRSMN1; SMN2 | |
| SCHEMBL5844975 | 0.99 | S1PR3 (0.39) | LMNAHTTS1PR3TSHRSMN1; SMN2 | |
| SCHEMBL5843996 | 0.99 | S1PR3 (0.39) | LMNAHTTS1PR3TSHRSMN1; SMN2 | |
| SCHEMBL5845625 | 0.99 | S1PR3 (0.39) | LMNAHTTS1PR3TSHRSMN1; SMN2 | |
| SCHEMBL5845626 | 0.96 | LMNA (0.38) | LMNAHTTS1PR3TSHRSMN1; SMN2 | |
| SCHEMBL382647 | 0.92 | HTT (0.43) | LMNAHTTS1PR3TSHRSMN1; SMN2 | |
| SCHEMBL5844982 | 0.91 | S1PR3 (0.39) | LMNAS1PR3MAPTS1PR5WDR5 | |
| SCHEMBL5844432 | 0.91 | MEN1 (0.38) | LMNAS1PR3THRATHRBMAPT | |
| SCHEMBL6737066 | 0.88 | THRA (0.40) | LMNAHTTS1PR3TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7101651-B2 | Sulfonyldiazomethanes, photoacid generators, resist compositions, and patterning process | SHIN-ETSU CHEMICAL CO.,LTD. (JP) | 2006-09-05 | — | — | US | disclosed |
| US-20040166432-A1 | Novel sulfonyldiazomethanes, photoacid generators, resist compositions, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040166432-A1 | Novel sulfonyldiazomethanes, photoacid generators, resist compositions, and patterning process | VEGFA, POLL, PIM3 | LMNA 597/4885HTT 2186/4885S1PR3 1891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.